忍无可忍，怒发冲冠！美国FDA简直是丧心病狂。
在评审委员会11位德高望重的专家集体反对（已经有两位愤而辞职），科学上根本没有定论关于淀粉蛋白与AZ（老年痴呆症）因果关系的情况下，FDA强行通过Biogen的所谓专门针对淀粉蛋白的AZ新药。。。are you kidding me？？？？
FDA傲慢自大的官老爷们，居然给了Biogen八年多的时间（until 2030），可以一边继续做4期，一边卖药。
Biogen的CEO刚刚给出了药价：一个疗程56000刀 ！远远高于wall street分析师预测的10000-25000。什么叫吃人不吐骨头？把一个多半是安慰剂的东东卖到56000刀，不服不行！
区区四年时间，曾经如此高大上以科学严谨著称的美国FDA，居然堕落得与shithole country的FDA毫无二致，(Exclusive: FDA enforcement actions plummet under Trump ...)
From monitoring clinical trials and approving medicines and vaccines, to ensuring the safety of blood transfusions, medical devices, groceries, and more, the U.S. Food and Drug Administration (FDA) is one of the nation’s most vital watchdogs. By several measures, however, FDA’s compliance and enforcement actions have plummeted since President Donald Trump took office, Science has found.
The agency’s “warning letters”—a key tool for keeping dangerous or ineffective drugs and devices and tainted foods off the market—have fallen by one-third, for example. Such letters typically demand swift corrections to protect public health and safety. FDA records from Trump’s inauguration through 22 May show the agency issued 1033 warning letters, compared with 1532 for the most recent equivalent period under former President Barack Obama. Compared with the start of the Obama presidency, Trump-era letters dropped by nearly half.
无语问苍天....
。。。。。。
。。。。。。
。。。。。。
。。。。。。
。。。。。。
。。。。。。
。。。。。。
。。。。。。
。。。。。。
不过，千万别误会。。。。
俺之所以有此冲冠一怒，不是因为忧国忧民，而是因为，借四嫂的话：见钱眼开
前天一大早，看到FDA 强行通过Biogen 治疗老年痴呆的新药的新闻后，我二话不说，立马就去 E trade 下单买进 Biogen 的股票！在288的价位下的单，但 E trade 居然赫然显示：
此股票暂时无法交易！！！！
等到能交易的时候，已经涨到了400！
发家致富的机会，就这么竹篮打水一场空了。您说说，能不怒发冲冠吗？！
打倒 FDA ！
打倒 Biogen ！
打倒 E trade ！
嗯，借四嫂的话。。。
打倒见钱眼开的爪四哥 ！
